Sirius Genomics Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pharmacogenomic Biomarker Study for Recombinant Human Activated Protein C Treatment in Severe Sepsis (NCT01486524) | Sirius Genomics Inc. | 2011-10-01 |
Track Sirius Genomics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.